HOME >> BIOLOGY >> NEWS
New Gene Therapy Strategy Keeps Muscles Strong In Old Age: Possibilities Seen For Disease Treatment, But Also For Athletic Or Cosmetic Enhancements

Scientists at the University of Pennsylvania Medical Center have developed a novel gene therapy treatment that permanently blocks the age-related loss of muscle size and strength in mice. Mice, like humans and all mammals, lose up to a third of their muscle mass and power with age. In humans, the result is an advancing weakness in the elderly that can lead to unsteadiness and impaired mobility, increased susceptibility to falls and injury, and joint stress and degeneration.

Even in young adult mice, the new treatment increased muscle strength by a dramatic 15 percent over untreated muscle. But in older mice, the improvement was even more remarkable: The researchers documented a 27 percent increase in strength over untreated muscle in these mice -- fully restoring their strength to what it was in young adulthood.

The technique suggests human therapies that could reverse the feebleness associated with old age or counter the muscle-wasting effects of muscular dystrophies and related diseases. It also raises the possibility, however, that the technique could be used -- or abused -- for athletic or cosmetic enhancements.

Results from the experimental study will be presented at the 38th annual meeting of the American Society for Cell Biology in San Francisco on December 14 and will be published in the December 22 issue of the Proceedings of the National Academy of Sciences. (Copies of the paper are available to reporters through the journal's news office, reachable by telephone at 202-334-2138 or by e-mail at pnasnews@nas.edu.)

"Our results show that it may be possible to preserve muscle size and strength in old age using this approach," says H. Lee Sweeney, PhD, professor of physiology and senior investigator on the study. "We're now looking to see whether the technique might also be used to increase muscle strength in diseases such as muscular dystrophy."

To de
'"/>

Contact: hokef@mail.med.upenn.edu
hokef@mail.med.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
14-Dec-1998


Page: 1 2 3

Related biology news :

1. 1st International Conference on Cell Therapy for Cardiovascular Disease
2. National Cancer Gene Therapy Foundation gives $4.0 million in research grants
3. Braunschweig Prize 2003 for Molecular Cancer Therapy
4. Alliance for Cancer Gene Therapy announces $1.5 million in national grants to young investigators
5. New research on safety of intracoronary delivery of adenovector reported in cover story of Molecular Therapy
6. Therapy hinders AIDS virus from evolving drug resistance, Hopkins researchers find
7. Invitation To Cover: American Society Of Gene Therapy Meeting
8. Gene Therapy For Pain
9. Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy
10. Shock Therapy Exceeds Expectations In Cleaning Up Contaminated Soils
11. Penn Researchers Develop Gene Therapy Technique That Reverses Muscle Membrane Weakness In Muscular Dystrophy Variant

Post Your Comments:
(Date:6/17/2013)... fungi, bacteria, and algae, is a common component of ... in the medical field it,s approved by the ... and used during surgery as a substance that opens ... drugs. , Now Profs. Ehud Gazit and Daniel Segal ... Biotechnology and the Sagol School of Neuroscience, along with ...
(Date:6/17/2013)... 2013) The AGA Research Foundation and Horizon Pharma ... of gastroenterology with the 2013 AGA-Horizon Pharma Fellow Abstract ... , "In its third year, this competition continues to ... on promising careers in basic and clinical research," said ... Research Foundation. "We are extremely proud of all that ...
(Date:6/17/2013)... CORVALLIS, Ore. Amphibian populations are declining worldwide and ... be spread by bullfrogs, but a two-year study shows ... suggestions that bullfrogs are a tolerant carrier host that ... frogs from eggs in controlled experimental conditions, they found ... dendrobatidis , also called Bd or a chytrid fungus, ...
Breaking Biology News(10 mins):Artificial sweetener a potential treatment for Parkinson's disease 2Horizon Pharma Abstract Prizes recognize promising fellows and students 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
(Date:6/18/2013)... Nasseo, Inc. today announces that it has been ... of applicants by the Arizona Commerce Authority (ACA) ... The Arizona Innovation Challenge (AIC) awards the most money ... a financial award to what it deems to be ... the art dental and orthopedic implant surface modification technology ...
(Date:6/18/2013)... June 18, 2013 The ... of the HELM biomolecular representation standard software toolkit ... licence. HELM (Hierarchical Editing Language for ... of biomolecules (e.g. proteins, nucleotides, antibody drug conjugates) ... sequence-based informatics methodologies impractical or unusable. HELM solves ...
(Date:6/18/2013)... Edison Investment Research, ... the initiation of full coverage of BioAlliance ... and marketing products for orphan oncology and ... (Logo: http://photos.prnewswire.com/prnh/20130417/608168) Edison has today ... merits of BioAlliance Pharma, focusing in particular ...
(Date:6/18/2013)... , June 18, 2013 The "Bioinformatics ... Platforms, Knowledge Management Tools & Data Analysis Services) & Application ... studies the Major Market Drivers, Restraints, and Opportunities in ... Asia-Pacific and Rest of World. ... 22 Figures ...
Breaking Biology Technology:Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3
Cached News: